6 items

Helper protein worsens diabetic eye disease

November 27, 2019

In a recent study using mice, lab-grown human retinal cells and patient samples, Johns Hopkins Medicine scientists say they found evidence of a new pathway that may contribute to degeneration of the light sensitive tissue at the back of the eye.

Therapy applied directly inside the eye best for treating uveitic macular edema

September 27, 2018

Delivery of corticosteroids directly into the eye is more effective than injections adjacent to the eye, according to results from a comparative clinical trial of macular edema in patients with noninfectious uveitis.

Avastin as effective as Eylea for treating central retinal vein occlusion

May 9, 2017

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial funded by the National Eye Institute (NEI)...

Eylea Outperforms Avastin for Diabetic Macular Edema with Moderate or Worse Vision Loss

February 25, 2016

A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that gains in vision were greater for participants receiving the drug Eylea (aflibercept) than for those receiving Avastin (bevacizumab)...

New Treatment Options, Better Hope of Preventing Vision Loss from Diabetes

November 19, 2015

This National Diabetes Month, there is some good news for people with eye complications from diabetes.

Lucentis Effective for Proliferative Diabetic Retinopathy

November 13, 2015

A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy.